Citius Pharmaceuticals, Inc. (CTXR)

Every figure this model derived for CTXR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2022-09-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 6,938 PaymentsToAcquirePropertyPlantAndEquipment 2021-09-30
cash 17,007,523 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 43,331,363 AssetsCurrent 2026-06-30
current liabilities 51,649,351 LiabilitiesCurrent 2026-06-30
equity 66,613,132 StockholdersEquity 2026-06-30
revenue 90,000 RevenueFromContractWithCustomerIncludingAssessedTax 2022-09-30
sbc 0 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up CTXR on one particular measure came for.

RatioValue
current ratio0.84
current ratio reported0.84
growth cv1.4
revenue growth0.0
revenue growth per share0.0
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about CTXR's figures. Written by the derivation as it ran, not added afterwards.